## Core Concept
Adrenoleukodystrophy (ALD) is a genetic disorder characterized by the breakdown or loss of the myelin sheath surrounding nerve cells in the brain and spinal cord, as well as the degeneration of the adrenal glands. This condition is caused by mutations in the ABCD1 gene, which is essential for the normal breakdown of very long-chain fatty acids (VLCFAs).

## Why the Correct Answer is Right
The correct answer, , implies that ALD is related to a defect in the ABCD1 gene leading to accumulation of VLCFAs. This accumulation disrupts the normal functioning of the adrenal glands and the nervous system, particularly affecting the myelin sheath. The mechanism involves impaired peroxisomal function, specifically in the breakdown of VLCFAs, leading to their accumulation and subsequent cellular damage.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because ALD is not primarily caused by a mitochondrial disorder but rather by a defect in a peroxisomal gene.
- **Option B:** This option is incorrect as it does not accurately describe the genetic or biochemical basis of ALD.
- **Option D:** This option is incorrect because, although adrenal dysfunction is a component of ALD, stating it as a simple adrenal disorder overlooks the significant neurological aspects of the disease.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that ALD often presents with a combination of neurological symptoms (such as vision and hearing loss, seizures, and muscle weakness) and adrenal insufficiency. Early diagnosis through genetic testing or measurement of VLCFA levels can be lifesaving, as it allows for interventions like hematopoietic stem cell transplantation and dietary modifications to reduce VLCFA levels.

## Correct Answer Line
**Correct Answer: C.**